Myelodysplastic syndromes

Cazzola, M. Myelodysplastic syndromes. N. Engl. J. Med. 383, 1358–1374 (2020). This review article discusses definitions, pathophysiology, diagnosis, risk stratification and therapy of MDS.

Article  CAS  PubMed  Google Scholar 

Bejar, R., Levine, R. & Ebert, B. L. Unraveling the molecular pathophysiology of myelodysplastic syndromes. J. Clin. Oncol. 29, 504–515 (2011).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Giagounidis, A. & Haase, D. Morphology, cytogenetics and classification of MDS. Best Pract. Res. Clin. Haematol. 26, 337–353 (2013).

Article  CAS  PubMed  Google Scholar 

Ma, X. Epidemiology of myelodysplastic syndromes. Am. J. Med. 125 (Suppl. 7), S2–S5 (2012). This review article discusses the epidemiology of MDS.

Article  PubMed  PubMed Central  Google Scholar 

National Cancer Institute. SEER Cancer Statistics Review, 1975-2016. Myelodysplastic Syndromes (MDS), Chronic Myeloproliferative Disorders (CMD), and Chronic Myelomonocytic Leukemia (CMML). National Cancer Institute http://seer.cancer.gov/csr/1975_2016/browse_csr.php?sectionSEL=30&pageSEL=sect_30_intro.01.html (2022).

Offman, J. et al. Defective DNA mismatch repair in acute myeloid leukemia/myelodysplastic syndrome after organ transplantation. Blood 104, 822–828 (2004).

Article  CAS  PubMed  Google Scholar 

Garcia-Manero, G., Chien, K. S. & Montalban-Bravo, G. Myelodysplastic syndromes: 2021 update on diagnosis, risk stratification and management. Am. J. Hematol. 95, 1399–1420 (2020).

Article  PubMed  Google Scholar 

Goldberg, S. L. et al. Incidence and clinical complications of myelodysplastic syndromes among United States Medicare beneficiaries. J. Clin. Oncol. 28, 2847–2852 (2010).

Article  PubMed  Google Scholar 

Rollison, D. E. et al. Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs. Blood 112, 45–52 (2008).

Article  CAS  PubMed  Google Scholar 

Steensma, D. P. The changing classification of myelodysplastic syndromes: what’s in a name? Hematol. Am. Soc. Hematol. Educ. Program https://doi.org/10.1182/asheducation-2009.1.645 (2009).

Article  Google Scholar 

Khoury, J. D. et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms. Leukemia 36, 1703–1719 (2022). This publication is the fifth edition of the WHO Classification of MDS.

Article  PubMed  PubMed Central  Google Scholar 

Valent, P. et al. Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: consensus statements and report from a working conference. Leuk. Res. 31, 727–736 (2007).

Article  PubMed  Google Scholar 

Estey, E., Hasserjian, R. P. & Dohner, H. Distinguishing AML from MDS: a fixed blast percentage may no longer be optimal. Blood 139, 323–332 (2022). This article discusses how to distinguish MDS from AML.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zeidan, A. M., Shallis, R. M., Wang, R., Davidoff, A. & Ma, X. Epidemiology of myelodysplastic syndromes: why characterizing the beast is a prerequisite to taming it. Blood Rev. 34, 1–15 (2019).

Article  PubMed  Google Scholar 

Slack, J., Nguyen, L., Naugler, C. & Rashid-Kolvear, F. Incidence of myelodysplastic syndromes in a major Canadian metropolitan area. J. Appl. Lab. Med. 3, 378–383 (2018).

Article  PubMed  Google Scholar 

Maynadie, M. et al. Epidemiological characteristics of myelodysplastic syndrome in a well-defined French population. Br. J. Cancer 74, 288–290 (1996).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Williamson, P. J., Kruger, A. R., Reynolds, P. J., Hamblin, T. J. & Oscier, D. G. Establishing the incidence of myelodysplastic syndrome. Br. J. Haematol. 87, 743–745 (1994).

Article  CAS  PubMed  Google Scholar 

Dinmohamed, A. G. et al. Trends in incidence, initial treatment and survival of myelodysplastic syndromes: a population-based study of 5144 patients diagnosed in the Netherlands from 2001 to 2010. Eur. J. Cancer 50, 1004–1012 (2014).

Article  PubMed  Google Scholar 

Gattermann, N. et al. Myelodysplastic syndromes: aspects of current medical care and economic considerations in Germany. Onkologie 31, 477–484 (2008).

Article  PubMed  Google Scholar 

Bonadies, N. et al. Trends of classification, incidence, mortality, and survival of MDS patients in Switzerland between 2001 and 2012. Cancer Epidemiol. 46, 85–92 (2017).

Article  PubMed  Google Scholar 

Avgerinou, C. et al. The incidence of myelodysplastic syndromes in Western Greece is increasing. Ann. Hematol. 92, 877–887 (2013).

Article  PubMed  PubMed Central  Google Scholar 

Moreno Berggren, D. et al. Prognostic scoring systems for myelodysplastic syndromes (MDS) in a population-based setting: a report from the Swedish MDS register. Br. J. Haematol. 181, 614–627 (2018).

Article  PubMed  Google Scholar 

Iglesias Gallego, M. et al. Incidence and characteristics of myelodysplastic syndromes in Ourense (Spain) between 1994–1998. Haematologica 88, 1197–1199 (2003).

PubMed  Google Scholar 

Gologan, R. Demo-geographical data of myelodysplastic syndrome based on a large sample of patients from a Romanian Hematological Center. J. BUON 15, 547–555 (2010).

CAS  PubMed  Google Scholar 

Semochkin, S., Tolstykh, T., Dudina, G. & Fink, O. Clinical and epidemiological characteristics of myelodysplastic syndromes in adults [Russian]. Georgian Med. News 252, 108–115 (2016).

Google Scholar 

Wang, W., Wang, H., Wang, X. Q. & Lin, G. W. First report of incidence of adult myelodysplastic syndrome in China. Ann. Hematol. 91, 1321–1322 (2012).

Article  PubMed  Google Scholar 

Park, E. H. et al. Nationwide statistical analysis of myeloid malignancies in Korea: incidence and survival rate from 1999 to 2012. Blood Res. 50, 204–217 (2015).

Article  PubMed  PubMed Central  Google Scholar 

Chihara, D. et al. Incidence of myelodysplastic syndrome in Japan. J. Epidemiol. 24, 469–473 (2014).

Article  PubMed  Google Scholar 

Rodger, E. J. & Morison, I. M. Myelodysplastic syndrome in New Zealand and Australia. Intern. Med. J. 42, 1235–1242 (2012).

Article  CAS  PubMed  Google Scholar 

Otrock, Z. K. et al. A nationwide non-interventional epidemiological data registry on myelodysplastic syndromes in Lebanon. Am. J. Blood Res. 5, 86–90 (2015).

PubMed  PubMed Central  Google Scholar 

Feliciano, S. V. M. et al. Incidence and mortality of myeloid malignancies in children, adolescents and young adults in Brazil: a population-based study. Cancer Epidemiol. 62, 101583 (2019).

Article  PubMed  Google Scholar 

Velez, A. et al. Incidence of myelodysplastic syndromes from a medical care program in Buenos Aires, Argentina. Clin. Lymphoma Myeloma Leuk. 19 (Suppl. 1), S346 (2019).

Article  Google Scholar 

Ma, X., Does, M., Raza, A. & Mayne, S. T. Myelodysplastic syndromes: incidence and survival in the United States. Cancer 109, 1536–1542 (2007).

Article  PubMed  Google Scholar 

Cronin, K. A., Ries, L. A. & Edwards, B. K. The surveillance, epidemiology, and end results (SEER) program of the National Cancer Institute. Cancer 120 (Suppl. 23), 3755–3757 (2014).

Article  PubMed  Google Scholar 

Craig, B. M., Rollison, D. E., List, A. F. & Cogle, C. R. Underreporting of myeloid malignancies by United States cancer registries. Cancer Epidemiol. Biomark. Prev. 21, 474–481 (2012).

Article  Google Scholar 

Cogle, C. R., Craig, B. M., Rollison, D. E. & List, A. F. Incidence of the myelodysplastic syndromes using a novel claims-based algorithm: high number of uncaptured cases by cancer registries. Blood 117, 7121–7125 (2011).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cogle, C. R. et al. High rate of uncaptured myelodysplastic syndrome cases and an improved method of case ascertainment. Leuk. Res. 38, 71–75 (2014).

Article  PubMed  Google Scholar 

Sant, M. et al. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood 116, 3724–3734 (2010).

Article  CAS  PubMed  Google Scholar 

Cogle, C. R. Incidence and burden of the myelodysplastic syndromes. Curr. Hematol. Malig. Rep. 10, 272–281 (2015).

Article  PubMed  PubMed Central  Google Scholar 

Niemeyer, C. M. & Baumann, I. Myelodysplastic syndrome in children and adolescents. Semin. Hematol. 45, 60–70 (2008).

Article  CAS  PubMed  Google Scholar 

Mian, S. A. & Bonnet, D. Nature or nurture? Role of the bone marrow microenvironment in the genesis and maintenance of Myelodysplastic syndromes. Cancers https://doi.org/10.3390/cancers13164116 (2021).

Article  PubMed  PubMed Central  Google Scholar 

留言 (0)

沒有登入
gif